Register entry

Santarus, Inc..

Data as of · How to read this entry

Registered sites
0
Active NDC listings
8
Labeller names
3
Live patents
0
Countries
0
Catalogue

Drug listings by form and route

8

8 active NDC listings: 8 human prescription drug. By marketing category: NDA 8.

Dosage formNDCs
tablet, film coated, extended release3
capsule2
powder, for suspension2
tablet, extended release1
RouteNDCs
oral8
Labeller name on the listingNDCs
santarus, inc..4
santarus, inc.3
santarus inc.1
Catalogue

Marketed products

8
BrandGeneric nameForm / routeNDC
Glumetzametformin hydrochloridetablet, film coated, extended release, oral68012-002NDA
Glumetzametformin hydrochloridetablet, film coated, extended release, oral68012-003NDA
Glumetzametformin hydrochloridetablet, film coated, extended release, oral68012-004NDA
Ucerisbudesonidetablet, extended release, oral68012-309NDA
ZEGERIDomeprazole and sodium bicarbonatepowder, for suspension, oral68012-052NDA
ZEGERIDomeprazole and sodium bicarbonatepowder, for suspension, oral68012-054NDA
ZEGERIDomeprazole and sodium bicarbonatecapsule, oral68012-102NDA
ZEGERIDomeprazole and sodium bicarbonatecapsule, oral68012-104NDA
Compare

Other companies listing omeprazole and sodium bicarbonate

Enquiry

Common questions

Is Santarus, Inc.. FDA approved?
Santarus, Inc.. holds no registered establishment of its own; 8 drug products are listed under its name in the National Drug Code Directory, made at sites registered to other firms.
What drugs does Santarus, Inc.. make?
8 products are listed under Santarus, Inc.. in the openFDA NDC Directory, most often as tablet, film coated, extended release; capsule; powder, for suspension. The full breakdown by dosage form and route is above. A listing count is not a sales figure.

Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.